Events & Ideas

Pinney Associates is honored to have been a part of the teams who worked tirelessly to achieve FDA approval of over-the-counter Opill, the first oral contraceptive to be made available without a prescription in the US (approved July 13, 2023). Popular Science’s 50 greatest innovations of 2023

September 19-20, 2023 | Bethesda, MD Lucy Owen and Christine Sweeney will be attending. VIEW CONFERENCE

Ashworth J, Davis VG, Mannion R, Hufford M   To be presented at the 85th CPDD Annual Scientific Meeting, Poster Session 2, June 19, 2023.

March 19-21, 2023 | Orlando, FL Lucy Owen will be attending VIEW CONFERENCE WEBSITE

Moderator David Spangler, J.D., Senior Vice President, Legal, Government Affairs & Policy, CHPA Speakers Bernie Simone, Vice President of Client Strategy and Rx-to-OTC Switch, Pinney Associates Clark Richardson, MPH, President & CEO, PEGUS Research, Inc. Mary Alice Lawless, Founder and Chief Client Officer, Biograph Inc. Francis E. Becker, M.D., FACP, Director, Division of Nonprescription Drugs… Read More

Bernie Simone, Vice President of Client Strategy and Rx-to-OTC Switch, Pinney Associates Presented at Rx-to-OTC Switch Symposium, Dynamic Global Events, March 15-16, 2021

Christine Sweeney, PhD, MPH, Director, Issues Management, Pinney Associates George Quesnelle, Senior Strategic Advisor, OTC Commercialization and Optimization, Pinney Associates Presented February 22, 2018   Visit Webinar Website

Christine Sweeney, PhD, MPH, Director, Issues Management, Pinney Associates George Quesnelle, Senior Strategic Advisor, OTC Commercialization and Optimization, Pinney Associates Presented February 8, 2018 View Webinar Website